Researchers reported iASPP, an inhibitor of p53, as a paradoxical suppressor of inflammation and oncogenic KRASG12D-driven pancreatic cancer tumorigenesis.
[Cell Death & Differentiation]
Home Newsletters p53 Inhibitor iASPP Is an Unexpected Suppressor of KRAS and Inflammation-Driven Pancreatic...
